There is evidence from clinical studies that increased Tregs [49] and decreased CD3+ and CD8+ T cells [51,52] in the peripheral blood and tumour samples of HCC patients carries worse prognosis as it is associated with reduced relapse-free survival [52]. This evidence concerns the gene CD8A and hepatocellular carcinoma.